StockData
GRI Bio, Inc. logo

GRI Bio, Inc. (GRI) stock

GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.35−0.05 (-3.54%)

Close on Nov 17, 2026Market cap $2.95MP/E –Yield –

GRI Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

GRI Bio's price to book ratio was 0.4× on Nov 11, 2026, against 91.9× a year earlier. Over the last 3 years it ranged from 0.2× to 446.6×, with a median of 15.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.4×−10.9
2025Dec 31, 202511.3×−435.2
2024Nov 29, 2024446.6×–

More GRI Bio figures

See a number that looks wrong?